New combo therapy may let some rectal cancer patients avoid surgery
NCT ID NCT07474103
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment plan for people with high-risk rectal cancer that hasn't spread. Patients get a short course of radiation, then a mix of chemotherapy and immunotherapy before considering surgery. If the cancer disappears completely, patients may choose a 'watch and wait' approach instead of immediate surgery. The goal is to see if this approach improves outcomes and possibly avoids the need for surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER, ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hongli Liu
RECRUITINGWuhan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.